• Silymarin and Silybin A Metabolic Workflows

  2026-08-17

  Build reproducible liver and adipocyte assays with purified Silybin A, emphasizing solvent control, dose-response design, and orthogonal metabolic readouts. A CRISPRi obesity study provides a practical framework for pairing adipose-targeted gene silencing with independent biochemical interventions while keeping causal claims appropriately bounded.

• Anti-Diabetic Drugs and Weight Loss in Type 2 Diabetes

  2026-08-17

  This 2021 Pharmacological Research review organizes non-insulin glucose-lowering therapies by their observed effects on body weight, BMI, and body composition in type 2 diabetes. Its clinically useful contribution is a comparative framework that places ertugliflozin among agents associated with moderate weight loss while distinguishing this effect from the stronger reductions reported for selected GLP-1 receptor agonists and tirzepatide.

• Regorafenib (BAY 73-4506) Research Guide

  2026-08-16

  Regorafenib, also called BAY 73-4506, is an orally active multikinase inhibitor for studying angiogenesis, oncogenic signaling, and tumor progression. Product data and a 2024 iScience study support its use in kinase assays, tumor xenograft models, and melanoma mechanism studies, while model-specific limits remain important.

• Balsalazide Disodium: UC Research Workflows

  2026-08-15

  Balsalazide disodium supports practical ulcerative colitis research, from soluble in vitro inflammation assays to colon-focused animal studies and radiotracer development. Its bacterial azoreductase activation and reference-backed radioiodination workflow help researchers connect compound exposure with localized disease biology.

• α-Linolenic Acid: Designing Causal Lipid Assays

  2026-08-15

  α-Linolenic Acid (ALA) is more than an omega-3 substrate: it is a controllable probe for lipid flux, membrane remodeling, and signaling. This guide translates recent arachidonic acid–immunity findings into rigorous assay-design principles while defining what ALA experiments can—and cannot—demonstrate.

• Central Circuits of Opioid Mechanical Hypersensitivity

  2026-08-14

  Yin et al. identify a lateral parabrachial nucleus–hypothalamus–spinal cord pathway that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study shows that selective central MOR activation can paradoxically promote mechanical pain hypersensitivity, providing a circuit framework for opioid receptor signaling research and chronic pain research.

• Protease Inhibitor Cocktail for Plant Assays

  2026-08-13

  Preserve labile plant proteins, phosphoproteins, and protein complexes with an EDTA-free inhibitor blend designed for extract-based workflows. This guide connects practical sample handling with the STOP1–STAR1 aluminum-resistance study, showing how better protein preservation can improve Western blot, co-immunoprecipitation, and mechanistic validation.

• Resazurin Cell Viability Assay Kit in Redox Biology

  2026-08-13

  Explore how the Resazurin Cell Viability Assay Kit converts cellular redox activity into actionable viability data. This guide connects assay design with the ROS-driven apoptosis findings reported in lymphoid malignancy research.

• HyperScribe™ Poly (A) Tailing Kit for mRNA Rescue

  2026-08-12

  Convert T7-generated RNA into a more translation-ready template for controlled transfection and micro-injection studies. The workflow is especially useful for testing wild-type versus mutant rescue constructs, where matched RNA integrity, polyadenylation, and delivery conditions are essential for interpretable results.

• GSK2606414: A Causal Map of ER Stress Signaling

  2026-08-12

  GSK2606414 is a selective PERK inhibitor for resolving how ER stress becomes inflammatory cell death. This article translates recent nucleus pulposus cell findings into a practical, causality-focused assay strategy for ER stress research and pathway validation.

• Arachidonic Acid: From Lipids to Stroke Translation

  2026-08-11

  A mechanistic and translational framework for using Arachidonic Acid to interrogate eicosanoid signaling, neuroinflammation, blood-brain barrier injury, and ischemia-reperfusion models—while distinguishing established evidence from testable hypotheses.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-10

  Saito and colleagues developed an accessible direct 3D cluster-culture protocol for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. The organoids produced intestinal epithelial monolayers containing mature cell types and enterocytes with cytochrome P450 and transporter activities, supporting more human-relevant pharmacokinetic studies.

• DIDS: Chloride Channel and TRPV1 Probe

  2026-08-09

  DIDS, also called 4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid, is a research anion transport inhibitor with reported activity against ClC-Ka, ClC-ec1, calcium-activated chloride currents, and TRPV1 signaling. Its preclinical profile supports mechanistic studies in ion transport, vascular physiology, neuroprotection, and hyperthermia tumor growth suppression, but its concentration-dependent and multi-target behavior limits interpretation as a selective blocker.

• ER-Targeted Peptide Self-Assembly in Cancer Cells

  2026-08-08

  The reference study develops an alkaline phosphatase (ALP)-instructed peptide that combines p-toluenesulfonamide-mediated endoplasmic reticulum targeting with enzyme-instructed self-assembly. In ALP-enriched cancer cells, the assemblies accumulate at the ER, induce ER stress and dysfunction, and promote apoptosis and necroptosis with an IC50 more than twofold lower than a non-targeted intracellular EISA design.

• PP 3: Src Kinase Control Compound Guide

  2026-08-07

  PP 3, also known as 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, is a research use only chemical used as a negative control for PP 2. Its principal value is experimental specificity: it helps distinguish Src kinase inhibitor-associated effects from solvent, scaffold, and off-target effects, but it does not independently prove Src dependence.

441 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page